Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

412 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Two-Year Efficacy and Safety Outcomes of the Pivotal OASIS Study Using the Revi System for Treatment of Urgency Urinary Incontinence.
Heesakkers JPFA, Toozs-Hobson P, Sutherland SE, Digesu A, Amundsen CL, McCrery RJ, De Wachter S, Kean ER, Martens F, Benson K, Ferrante KL, Cline KJ, Padron OF, Giusto L, Lane FL, Witte LPW, Dmochowski RR. Heesakkers JPFA, et al. Among authors: benson k. J Urol. 2024 Nov 25:101097JU0000000000004328. doi: 10.1097/JU.0000000000004328. Online ahead of print. J Urol. 2024. PMID: 39585851
Treatment of Urinary Urgency Incontinence Using a Rechargeable SNM System: 6-Month Results of the ARTISAN-SNM Study.
McCrery R, Lane F, Benson K, Taylor C, Padron O, Blok B, De Wachter S, Pezzella A, Gruenenfelder J, Pakzad M, Perrouin-Verbe MA, Le Normand L, Van Kerrebroeck P, Mangel J, Peters K, Kennelly M, Shapiro A, Lee U, Comiter C, Mueller M, Goldman HB. McCrery R, et al. Among authors: benson k. J Urol. 2020 Jan;203(1):185-192. doi: 10.1097/JU.0000000000000458. Epub 2019 Jul 26. J Urol. 2020. PMID: 31347955
A prospective study to assess the effectiveness and safety of the BlueWind System in the treatment of patients diagnosed with urgency urinary incontinence.
Heesakkers JPFA, Toozs-Hobson P, Sutherland SE, Digesu A, Amundsen CL, McCrery RJ, De Wachter S, Kean ER, Martens F, Benson K, Ferrante KL, Cline KJ, Padron OF, Giusto L, Lane FL, Dmochowski RR. Heesakkers JPFA, et al. Among authors: benson k. Neurourol Urodyn. 2024 Sep;43(7):1491-1503. doi: 10.1002/nau.25477. Epub 2024 Apr 18. Neurourol Urodyn. 2024. PMID: 38634481 Clinical Trial.
One-year outcomes of the ARTISAN-SNM study with the Axonics System for the treatment of urinary urgency incontinence.
Benson K, McCrery R, Taylor C, Padron O, Blok B, de Wachter S, Pezzella A, Gruenenfelder J, Pakzad M, Perrouin-Verbe MA, Van Kerrebroeck P, Mangel J, Peters K, Kennelly M, Shapiro A, Lee U, Comiter C, Mueller M, Goldman H, Lane F. Benson K, et al. Neurourol Urodyn. 2020 Jun;39(5):1482-1488. doi: 10.1002/nau.24376. Epub 2020 Apr 27. Neurourol Urodyn. 2020. PMID: 32339339 Free PMC article.
Two-year outcomes of the ARTISAN-SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation system.
Pezzella A, McCrery R, Lane F, Benson K, Taylor C, Padron O, Blok B, de Wachter S, Gruenenfelder J, Pakzad M, Perrouin-Verbe MA, van Kerrebroeck P, Mangel J, Peters K, Kennelly M, Shapiro A, Lee U, Comiter C, Mueller M, Goldman HB. Pezzella A, et al. Among authors: benson k. Neurourol Urodyn. 2021 Feb;40(2):714-721. doi: 10.1002/nau.24615. Epub 2021 Jan 28. Neurourol Urodyn. 2021. PMID: 33508155 Free PMC article.
Reply by Authors.
McCrery R, Lane F, Benson K, Taylor C, Padron O, Blok B, De Wachter S, Pezzella A, Gruenenfelder J, Pakzad M, Perrouin-Verbe MA, Le Normand L, Van Kerrebroeck P, Mangel J, Peters K, Kennelly M, Shapiro A, Lee U, Comiter C, Mueller M, Goldman HB. McCrery R, et al. Among authors: benson k. J Urol. 2020 Jan;203(1):192. doi: 10.1097/01.JU.0000602784.69147.96. Epub 2019 Oct 3. J Urol. 2020. PMID: 31580190 No abstract available.
Iltamiocel Autologous Cell Therapy for the Treatment of Female Stress Urinary Incontinence: A Double-Blind, Randomized, Stratified, Placebo-Controlled Trial.
Kaufman MR, Goldman HB, Chermansky CJ, Dmochowski R, Kennelly MJ, Peters KM, Quiroz LH, Bennett JB, Thomas S, Marguet CG, Benson KD, Lee UJ, Sokol ER, Wolter CE, Katz DM, Tarnay CM, Antosh D, Heit MH, Rehme C, Karram M, Snyder S, Canestrari E, Jankowski RJ, Chancellor MB. Kaufman MR, et al. Among authors: benson kd. Neurourol Urodyn. 2024 Nov;43(8):2290-2299. doi: 10.1002/nau.25588. Epub 2024 Sep 16. Neurourol Urodyn. 2024. PMID: 39282854 Clinical Trial.
Rationale and design of an implant procedure and pivotal study to evaluate safety and effectiveness of Medtronic's tibial neuromodulation device.
Lee UJ, Xavier K, Benson K, Burgess K, Harris-Hicks JE, Simon R, Proctor JG, Bittner KC, Stolen KQ, Irwin CP, Offutt SJ, Miller AE, Michaud EM, Falkner PC, Coetzee JC. Lee UJ, et al. Among authors: benson k. Contemp Clin Trials Commun. 2023 Aug 22;35:101198. doi: 10.1016/j.conctc.2023.101198. eCollection 2023 Oct. Contemp Clin Trials Commun. 2023. PMID: 37691849 Free PMC article.
412 results